174 related articles for article (PubMed ID: 17078183)
1. Predictors for high costs of hospital care in elderly hypertensive patients.
Linjer E; Jörnmark J; Hedner T; Jönsson B;
Blood Press; 2006; 15(4):245-50. PubMed ID: 17078183
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the association between blood pressure control and health care resource use.
Lapuerta P; Simon T; Smitten A; Caro J;
Clin Ther; 2001 Oct; 23(10):1773-82. PubMed ID: 11726010
[TBL] [Abstract][Full Text] [Related]
5. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
[TBL] [Abstract][Full Text] [Related]
6. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
7. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
8. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
Schäfer HH; Scheunert U
Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
[TBL] [Abstract][Full Text] [Related]
9. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
Dickson M; Plauschinat CA
Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
[TBL] [Abstract][Full Text] [Related]
10. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers?
Saseen JJ; MacLaughlin EJ; Westfall JM
J Am Board Fam Pract; 2003; 16(2):156-64. PubMed ID: 12665182
[No Abstract] [Full Text] [Related]
11. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
12. [Pharmaco-economic aspects of the treatment of hypertension].
Delporte JP; Rorive G
Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
[TBL] [Abstract][Full Text] [Related]
13. Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.
Cobiac LJ; Magnus A; Barendregt JJ; Carter R; Vos T
BMC Public Health; 2012 Jun; 12():398. PubMed ID: 22657090
[TBL] [Abstract][Full Text] [Related]
14. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group
BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
[TBL] [Abstract][Full Text] [Related]
16. An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.
Ramsey SD; Neil N; Sullivan SD; Perfetto E
J Am Board Fam Pract; 1999; 12(2):105-14. PubMed ID: 10220232
[TBL] [Abstract][Full Text] [Related]
17. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report.
Lindholm LH; Hansson L; Dahlöf B; Ekbom T; Hedner T; De Faire U; Scherstén B; Wester PO
Blood Press; 1996 Sep; 5(5):300-4. PubMed ID: 8879603
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of elderly patients with hypertension--complications and current drug therapy].
Takagawa Y; Shimamoto K; Masuda A; Iimura O
Nihon Ronen Igakkai Zasshi; 1997 Jan; 34(1):30-7. PubMed ID: 9077102
[TBL] [Abstract][Full Text] [Related]
19. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
